Engineering Layered Nanomaterials for Cancer Theranostics: Current Progress and Future Opportunities
Angewandte Chemie International Edition · 01.07.2026 · 65 (27)
DOI: 10.1002/anie.1634100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 19.05.2026. Verfasst von Xiangrong Pan und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Henan Key Laboratory of Function-Oriented Porous Materials, Luoyang Normal University, Luoyang, P. R. …. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Neoplasms, Nanostructures. Die Arbeit nennt 330 Literaturangaben. Gefördert von: National Natural Science Foundation of China-Excellent Young Scientists Fund, National Natural Science Foundation of Henan, National Key Research and Development Program of China.
Abstract (Originalsprache)
Atomic‐level structural engineering represents a powerful paradigm for tailoring layered nanomaterials (LNs) toward advanced cancer theranostics, enabling precise control of physicochemical properties to overcome the limitations of conventional nanoplatforms. This review provides a comprehensive overview of the latest advances in engineering LNs, including layered metal oxides, layered double hydroxides, transition metal dichalcogenides, graphene, layered silicates, graphitic carbon nitride, metal carbides and nitrides, and other layered frameworks for cancer diagnosis and therapy. Five representative atomic‐level engineering strategies are discussed, including crystal phase engineering, defect engineering, heteroatom doping, interlayer spacing engineering, and crystalline‐to‐amorphous phase engineering. For each strategy, the underlying mechanisms, representative synthetic approaches, and their roles in optimizing theranostic performance, such as photothermal conversion, reactive oxygen species generation, and multimodal imaging, are critically discussed. Crucially, the advantages and inherent limitations of these engineering strategies are comparatively evaluated to provide a balanced perspective on their practical applicability. Finally, key challenges toward clinical translation, including structural stability, biosafety, and scalability, are highlighted. Future directions are proposed for developing intelligent, adaptive, and personalized LN‐based nanomedicines for precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Henan Key Laboratory of Function-Oriented Porous Materials, Luoyang Normal University, Luoyang, P. R. China.
- Department of Electrical Engineering & Department of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong SAR, P. R. China.
- State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, P. R. China.
- Dongguan Key Laboratory of Advanced Drug Delivery and Biosensing Research and Development, School of Pharmacy, and Dongguan Innovation Institute, Guangdong Medical University, Dongguan, P. R. China.
- Hong Kong Branch of National Precious Metals Material Engineering Research Center (NPMM), City University of Hong Kong, Kowloon, Hong Kong SAR, P. R. China.
- Shenzhen Research Institute, City University of Hong Kong, Shenzhen, P. R. China.
ORCID-Profile: Xiaoyan Lu, Yubin Zhou, Zhan Zhou, Ruizheng Liang, Chaoliang Tan
Förderung
- National Natural Science Foundation of China-Excellent Young Scientists Fund
- National Natural Science Foundation of Henan
- National Key Research and Development Program of China
- Interdisciplinary Research Center of Beijing University of Chemical Technology
- Shenzhen Basic Research General Program from Science, Technology and Innovation Bureau of Shenzhen Municipality
- Start-Up Grant from City University of Hong Kong
- Natural Science Foundation for Excellent Young Scholars of Henan Province
- ITC via Hong Kong Branch of National Precious Metals Material Engineering Research Center (NPMM)
Zitieren
APA
Pan, X., Hu, T., Zhang, Y., Lu, X., Chen, H., Zhou, Y., Ma, L., Zhou, Z., Liang, R., & Tan, C. (2026). Engineering Layered Nanomaterials for Cancer Theranostics: Current Progress and Future Opportunities. Angewandte Chemie International Edition, 65(27). https://doi.org/10.1002/anie.1634100
Vancouver
Pan X, Hu T, Zhang Y, Lu X, Chen H, Zhou Y, et al. Engineering Layered Nanomaterials for Cancer Theranostics: Current Progress and Future Opportunities. Angewandte Chemie International Edition. 2026;65(27). doi:10.1002/anie.1634100
BibTeX
@article{Pan2026,
author = {Pan, Xiangrong and Hu, Tingting and Zhang, Yajie and Lu, Xiaoyan and Chen, Huizhi and Zhou, Yubin and Ma, Lufang and Zhou, Zhan and Liang, Ruizheng and Tan, Chaoliang},
title = {Engineering Layered Nanomaterials for Cancer Theranostics: Current Progress and Future Opportunities},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {27},
doi = {10.1002/anie.1634100}
}
EUVIMED